Nuo Therapeutics Financials

$162.2 K

Revenue Q3, 2017
Net income (Q3, 2017)(1.4 M)
EBIT (Q3, 2017)(1.4 M)
Cash, 30-Sep-20171.9 M

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

11.6 m7.8 m11.5 m472.4 k

Revenue growth, %

(33%)48%(96%)

Cost of goods sold

8.4 m6.6 m

Gross profit

3.2 m1.2 m

Gross profit Margin, %

28%15%

Sales and marketing expense

6.2 m893.1 k

R&D expense

2.6 m1 m

General and administrative expense

6.8 m6 m9 m3.3 m

Operating expense total

6.8 m6 m17.8 m5.2 m

EBIT

(18.1 m)(23.4 m)(41.3 m)(5.5 m)

EBIT margin, %

(156%)(301%)(359%)(1155%)

Interest expense

1.7 m3.4 m3.8 m2.2 k

Pre tax profit

(20.2 m)(18.9 m)

Income tax expense

18.6 k19.6 k(89 k)

Net Income

(20.2 m)(18.9 m)(52.8 m)(5.7 m)

    Quarterly

    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

    Revenue

    2.3 m1.7 m4.8 m2.9 m2.2 m1.4 m134.9 k176.8 k172.7 k162.2 k

    Cost of goods sold

    1.9 m1.3 m

    Gross profit

    473.1 k401.6 k

    Gross profit Margin, %

    20%24%

    Sales and marketing expense

    1.8 m1.8 m1.6 m563.8 k237.3 k331.6 k213.7 k

    R&D expense

    734.5 k597.8 k515.2 k375.2 k224.4 k323.5 k399.4 k

    General and administrative expense

    1.3 m1.8 m2.8 m2.6 m2 m1.7 m602.8 k1.1 m974.4 k

    Operating expense total

    1.3 m1.8 m5.4 m5 m4.1 m2.6 m1.1 m1.8 m1.6 m1.3 m

    EBIT

    (9.8 m)(4.5 m)(3.4 m)(4.4 m)(27.3 m)(2 m)(1.1 m)(1.9 m)(1.7 m)(1.4 m)

    EBIT margin, %

    (422%)(266%)(70%)(153%)(1257%)(140%)(820%)(1050%)(975%)(848%)

    Interest expense

    589.7 k818.5 k867 k912.6 k967 k206.2 k1091.1 k6.6 k3.9 k

    Pre tax profit

    (11.3 m)(4.8 m)(13.8 m)

    Income tax expense

    4.6 k4.6 k4.9 k4.9 k4.9 k

    Net Income

    (4.8 m)4.1 m(870.2 k)(13.8 m)(4.9 m)(1.3 m)(1.9 m)(1.7 m)(1.4 m)

      Balance Sheet

      Annual

      USDFY, 2013FY, 2014FY, 2015FY, 2016

      Cash

      3.3 m15.9 m922.3 k2.6 m

      Inventories

      1.3 m2.3 m804.5 k70 k

      Current Assets

      10 m21.9 m3 m3.4 m

      PP&E

      919.5 k925.2 k1.1 m486.1 k

      Goodwill

      1.1 m1.1 m2.1 m

      Total Assets

      46.3 m56.2 m7.1 m14.1 m

      Accounts Payable

      8 m1.9 m1.1 m392.6 k

      Short-term debt

      3.6 m

      Current Liabilities

      10.6 m8.5 m42.2 m1.4 m

      Long-term debt

      3.6 m

      Total Debt

      7.2 m

      Total Liabilities

      1.6 m

      Common Stock

      993

      Preferred Stock

      3

      Additional Paid-in Capital

      117.1 m125.2 m126 m18.2 m

      Retained Earnings

      (91.2 m)(110.1 m)(162.9 m)(5.7 m)

      Total Equity

      26.3 m15.5 m(36.6 m)12.5 m

      Debt to Equity Ratio

      0.3 x

      Debt to Assets Ratio

      0.2 x

      Financial Leverage

      1.8 x3.6 x-0.2 x1.1 x

        Quarterly

        USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

        Cash

        25 m20 m11.8 m6.9 m4.1 m685.5 k6.1 m3.9 m1.3 m1.9 m

        Inventories

        591.6 k544.7 k1 m717.1 k603.8 k158.6 k78.1 k48.2 k64.7 k367.5 k

        Current Assets

        30.6 m25.7 m18.6 m12.8 m12.3 m3.1 m8.1 m5.6 m2.1 m2.6 m

        PP&E

        706.4 k757.2 k999.1 k874.1 k865.1 k983.7 k787.3 k691.1 k388.4 k

        Goodwill

        1.1 m1.1 m1.1 m1.1 m2.1 m2.1 m

        Total Assets

        65.3 m60.3 m52.7 m46.5 m19.2 m6.9 m19.6 m16.7 m12.4 m10.2 m

        Accounts Payable

        8.4 m1.7 m2 m1.7 m2.5 m728.9 k1.3 m498.3 k378.3 k434.5 k

        Current Liabilities

        8.8 m7 m9 m7.9 m11.9 m2.6 m1.7 m1.5 m1.7 m

        Total Liabilities

        1.7 m

        Common Stock

        993993

        Preferred Stock

        33

        Additional Paid-in Capital

        123.4 m124.8 m125.5 m125.7 m125.8 m126 m18.1 m18.1 m18.2 m21.1 m

        Retained Earnings

        (108.2 m)(113 m)(106 m)(106.9 m)(120.7 m)(167.8 m)(1.3 m)(3.2 m)(7.4 m)(12.7 m)

        Total Equity

        15.6 m12.3 m19.9 m19.2 m5.5 m(41.4 m)16.8 m14.9 m10.8 m8.5 m

        Financial Leverage

        4.2 x4.9 x2.6 x2.4 x3.5 x-0.2 x1.2 x1.1 x1.1 x1.2 x

          Cash Flow

          Annual

          USDFY, 2013FY, 2014FY, 2015FY, 2016

          Net Income

          (20.2 m)(18.9 m)(52.8 m)(5.7 m)

          Depreciation and Amortization

          1.1 m613.5 k741 k836.2 k

          Inventories

          (210.2 k)(1.1 m)272 k(21.6 k)

          Accounts Payable

          5.2 m(1.5 m)(811 k)(2.5 m)

          Cash From Operating Activities

          (11.4 m)(17.4 m)(14.4 m)(7.8 m)

          Cash From Investing Activities

          1.4 m(349.2 k)(629.4 k)100 k

          Cash From Financing Activities

          10.7 m30.4 m

            Quarterly

            USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

            Net Income

            (4.8 m)4.1 m(870.2 k)(13.8 m)(4.9 m)(1.3 m)(1.9 m)(1.7 m)(1.4 m)

            Inventories

            591.6 k544.7 k367.5 k

            Accounts Payable

            8.4 m1.7 m2 m1.7 m2.5 m728.9 k1.3 m498.3 k378.3 k434.5 k

              Ratios

              Y, 2017

              Financial Leverage

              1.2 x